Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial
-
Published:2024-09
Issue:9
Volume:42
Page:1570-1581.e4
-
ISSN:1535-6108
-
Container-title:Cancer Cell
-
language:en
-
Short-container-title:Cancer Cell
Author:
Xiao Wei-Wei, Chen Gong, Gao Yuan-Hong, Lin Jun-Zhong, Wu Xiao-Jun, Luo Hui-Long, Lu Zhen-Hai, Wang Qiao-Xuan, Sun Rui, Cai Pei-Qiang, Zhu Chong-Mei, Liu Min, Li Ji-Bin, Wang Yi-Rui, Jin Ying, Wang Feng, Luo Hai-Tao, Li Cai-Ling, Pan Zhi-Zhong, Xu Rui-HuaORCID
Reference71 articles.
1. Preoperative versus postoperative chemoradiotherapy for rectal cancer;Sauer;N. Engl. J. Med.,2004 2. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years;Sauer;J. Clin. Oncol.,2012 3. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial;Bahadoer;Lancet Oncol.,2021 4. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial;Conroy;Lancet Oncol.,2021 5. Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis;Liu;Oncologist,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|